748P Outcomes for patients (pts) with advanced endometrial cancer (aEC) who completed pembrolizumab (pembro) and continued lenvatinib (LEN) in the phase III Study 309/KEYNOTE-775

Articles > Article · 2023

Authors: E. Colomba, D. Lorusso, H. Mackay, R. Moore, K. Yonemori, Y.M. Kim, U.A. Sanli, R. Xie, G. Barresi, J. McKenzie, V. Makker

Annals of Oncology, International, WoS, 2023, vol 34, pp S512-S513